Despite Near-Term Headwinds, Baxter Aims for a Turnaround Under New Management
Although the 2015 Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical utilization rising, supply chain pressures easing, and new contracts with group purchasing organizations coming online, Baxter's profits remain in turnaround mode.